Who We Are?

News Times-HD proudly stands at the forefront of Pakistan’s news websites, offering an unswerving commitment to delivering real-time, pinpoint-accurate coverage across the spectrum of current affairs, business analytics, sports fervor, cutting-edge tech revelations, and groundbreaking health insights. Our exceptional team of seasoned journalists and astute analysts works tirelessly to ensure you are consistently updated with the latest news and global events, sourced from both Pakistan and around the world. Our paramount objective is to keep our readers not only informed but fervently engaged with the ever-evolving world that surrounds them.

Developed By ASK

Tag: Novo Nordisk A/S

Eli Lilly’s weight loss pill orforglipron clears its latest trial, paving way for approval

A world on weight loss drugs: How GLP-1s are reshaping the economy

Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors

FDA approves first-ever glucose monitoring system for weight loss from Signos

Viking Therapeutics shares fall 40% on disappointing obesity pill trial data

Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients

Eli Lilly shares drop after obesity pill shows modest late-stage trial results

Eli Lilly earnings are coming Thursday. Here’s what top analysts expect

LATEST POSTS

Alicia Silverstone reveals why she’s ‘burning the candle so hard’

King Charles finds himself pleading to Camilla, Meghan to let Harry return to royal family

‘House of Dynamite’ writer pushes back on official claim

POPULAR CATEGORY

POPULAR POSTS

Alicia Silverstone reveals why she’s ‘burning the candle so hard’

10/28: The Daily Report

Walking: Forget the 10k step rule? Experts reveal how much walking is actually enough |

Who We Are?